Literature DB >> 22694174

Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011.

Joseph J Y Sung1, Enders K W Ng, Jaw-Town Lin, K Y Ho, Jia-Fu Ji, Kentaro Sugano, Ronnie T P Poon, Anthony T C Chan, Khean-Lee Goh, Kwang-Hyub Han, Leo L T Chen, Kai-Chun Wu, Simon S M Ng, Robert S Bresalier, Francis K L Chan.   

Abstract

BACKGROUND AND AIM: With the rising incidence of digestive cancers in the Asia Pacific region and the advancement in diagnosis, management and palliation in these conditions, the clinical burden on oncologists is ever increasing. This Summit meeting was called to discuss the optimal management of digestive cancers and the role of Gastroenterologists.
METHOD: Experts from Asia Pacific countries in the fields of medical, oncologic, surgical and endoscopic management of cancers in the esophagus, stomach, colon/rectum and the liver reviewed the literature and their practice. 18 position statements were drafted, debated and voted.
RESULTS: It was agreed that the burden on GI cancer is increasing. More research will be warranted on chemotherapy, chemoprevention, cost-effectiveness of treatment and nutrition. Cancer management guidelines should be developed in this region when more clinical data are available. In order to improve care to patients, a multi-disciplinary team coordinated by a "cancer therapist" is proposed. This cancer therapist can be a gastroenterologist, a surgeon or any related discipline who have acquired core competence training. This training should include an attachment in a center-of-excellence in cancer management for no less than 12 months.
CONCLUSION: The management of GI cancer should be an integrated multi-disciplinary approach and training for GI cancer therapists should be provided for.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22694174     DOI: 10.1111/j.1440-1746.2012.07194.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

1.  Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials.

Authors:  Tao Fu; Zhao-De Bu; Zi-Yu Li; Lian-Hai Zhang; Xiao-Jiang Wu; Ai-Wen Wu; Fei Shan; Xin Ji; Qiu-Shi Dong; Jia-Fu Ji
Journal:  BMC Cancer       Date:  2015-04-28       Impact factor: 4.430

2.  Association between Genetic Polymorphisms in DEFB1 and Susceptibility to Digestive Diseases.

Authors:  Yin-Peng Huang; Tian-Yi Wang; Wei Wang; Hong-Zhi Sun
Journal:  Med Sci Monit       Date:  2015-08-02

Review 3.  Burden of gastrointestinal cancer in Asia; an overview.

Authors:  Mohamad Amin Pourhoseingholi; Mohsen Vahedi; Ahmad Reza Baghestani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

4.  A 25-year trend in gastrointestinal cancers in northern Iran (1991-2016).

Authors:  Hakimeh Mehdizadeh; Ghahraman Mahmoudi; Dariush Moslemi; Ali Bijani; Mohammad Ali Jahani
Journal:  Caspian J Intern Med       Date:  2019

5.  Connective Tissue Growth Factor in Digestive System Cancers: A Review and Meta-Analysis.

Authors:  Feng Zhao; Chan Li; Yun Wu; Jianling Xia; Ming Zeng; Tao Li; Ke Xie
Journal:  Biomed Res Int       Date:  2020-12-27       Impact factor: 3.411

6.  Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study.

Authors:  Rongxu Du; Jiao Ming; Jianhao Geng; Yongheng Li; Ziyu Li; Weihu Wang; Xianggao Zhu; Yangzi Zhang; Shuai Li; Zhiyan Liu; Hongzhi Wang; Zhilong Wang; Lei Tang; Xiaotian Zhang; Aiwen Wu; Zhaode Bu; Yan Yan; Zhongwu Li
Journal:  Radiat Oncol       Date:  2022-03-03       Impact factor: 3.481

7.  Enhancing proficiency in performing endoscopic submucosal dissection (ESD) by using a prototype robotic endoscope.

Authors:  Philip WaiYan Chiu; Soo Jay Phee; Pradeep Bhandari; Kazuki Sumiyama; Tomohiko Ohya; Jennie Wong; Carmen Cy Poon; Hisao Tajiri; Kiyokazu Nakajima; Khek Yu Ho
Journal:  Endosc Int Open       Date:  2015-10-14

8.  Correlation Between Interleukin-1β-511 C/T Polymorphism and Gastric Cancer in Chinese Populations: A Meta-Analysis.

Authors:  Bo Chen; Ming-Xu Luo; Xin Zhou; Yo Lv; Guo-Qiang Su
Journal:  Med Sci Monit       Date:  2016-05-24

9.  Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.

Authors:  Bo Chen; Qi-Cong Luo; Jian-Bo Chen; Li-E Lin; Ming-Xu Luo; Hong-Yue Ren; Pei-Qiong Chen; Lian-Guo Shi
Journal:  Tumour Biol       Date:  2016-03-30

10.  Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers.

Authors:  Yaling Dou; Yali Lv; Xiaojin Zhou; Linfu He; Lihong Liu; Pengfei Li; Yulong Sun; Minghui Wang; Meijuan Gao; Chong Wang
Journal:  Onco Targets Ther       Date:  2018-03-28       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.